Management holds a conference call to discuss the Corporate Mid-Year Update on NurOwn Program on July 8 at 8 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCLI:
- BrainStorm to sell 11.11M shares at 36c in registered direct offering
- BrainStorm reached alignment with FDA on Phase 3b clinical trial for NurOwn
- Brainstorm Cell Therapeutics Appoints New EVP and COO
- BrainStorm appoints Haro Hartounian as COO
- BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update